In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

Brought to you by

Stereotaxis completes $44mm IPO

Executive Summary

Three months after its IPO filing, Stereotaxis (cardiology instrument control systems) has completed its offering on Nasdaq, netting $44.4mm (including a 460k overallotment) through the sale of 5.9mm shares at $8 apiece. It had originally hoped to raise up to $115mm by selling a million more shares priced in the $14-16 range.
Deal Industry
  • Medical Devices
  • Medical Devices
    • Implantable Devices
    • Surgical Equipment & Devices
Deal Status
  • Final
Deal Type
  • Financing
    • IPO

Related Companies